Compounders Podcast
The Investment Case for Canadian MicroCaps with Mathieu Martin, Portfolio Manager of the Rivemont MicroCap Fund
Jul 25, 2024
Mathieu Martin is a microcap specialist and Portfolio Manager of the Rivemont MicroCap Fund, with a keen eye on Canadian stocks. He shares how his love for microcaps ignited and discusses the inefficiencies he observes in this market. U.S. investors often overlook these opportunities, but Mathieu highlights the current undervaluation of Canadian microcaps, especially in sectors like technology and healthcare. He also reflects on the lessons learned from a tough year in 2022 and emphasizes the importance of disciplined research and risk management in navigating this unique investment landscape.
01:05:59
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Mathieu Martin's passion for microcap stocks originated from his entrepreneurial background, emphasizing the importance of identifying market inefficiencies in this segment.
- The Canadian microcap market is significantly undervalued, particularly in non-resource sectors, offering unique investment opportunities for retail investors.
Deep dives
Matthew Martin's Journey into Microcaps
Matthew Martin's interest in microcap stocks stems from his background in entrepreneurship, instilled by his parents who were small business owners. Initially unsure of his career path, he ventured into poker, where he gained financial skills and an understanding of risk and volatility. A friend introduced him to microcap investing, leading him to develop a strategy capitalizing on market inefficiencies. His journey included writing educational content and ultimately launching the Riemann Microcap Fund, focusing on identifying undervalued microcap opportunities.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
